Juan Carlos Garcia Pagan

, Spain


Chair(s)

Chair - Meet the Experts: Portosinusoidal vascular disease: what is there behind this new name? 14 April 2019 08:30 - 09:20
Meet the Experts
More ...
Chair - Parallel session: Portal Hypertension - Refining risk stratification and therapy 11 April 2019 16:00 - 18:00
Science/Research
More ...
Chair - Skills in hepatology: Vascular liver disease board 10 April 2019 10:00 - 11:00
Skills in Hepatology
More ...

Presentations

Prevention of variceal bleeding and medical management of acute variceal bleeding 10 April 2019 14:05 - 14:20
Factors predicting survival in patients with high-risk acute variceal bleeding treated with pre-emptive (Early)-TIPS 11 April 2019 17:30 - 17:45
Case presentation 10 April 2019 10:00 - 10:00

Abstracts

Anti-VHC therapy does not increase de risk of developing splanchnic vein thrombosis in patients with cirrhosis Viral Hepatitis C: Post SVR and long term follow up More
Factor V and VIII may predict the risk of recurrent splanchnic thrombosis in patients with non-cirrhotic chronic portal vein thrombosis of local and idiopathic etiology not receiving anticoagulation Rare liver diseases (including pediatric and genetic) More
Role of next generation sequencing in the etiological diagnosis of splanchnic venous thrombosis Rare liver diseases (including pediatric and genetic) More